作者：
Metzger-Filho,O. [1]
;
deAzambuja,E. [2]
;
Bradbury,I. [3]
;
Saini,K.S. [4]
;
Bines,J. [5]
;
Simon,S.D. [6]
;
vanDooren,V. [7]
;
Aktan,G. [8]
;
Pritchard,K.I. [9]
;
Wolff,A.C. [10]
;
Smith,I. [11]
;
Jackisch,C. [12]
;
Lang,I. [13]
;
Untch,M. [14]
;
Boyle,F. [15]
;
Xu,B. [16]
;
Baselga,J. [17]
;
Perez,E.A. [18]
;
Piccart-Gebhart,M.
作者单位：
Division Hematology/Oncology Memorial Sloan-Kettering Cancer Center, New York, NY, United States
[1]
Grupo Brasileiro de Estudos do Cancer de Mama (GBECAM) S?o Paulo, Brazil, Departamento de Oncologia
[2]
Department of Oncology, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD, United
[3]
Department of Gynecology and Obstetrics, Klinikum Offenbach, Germany
[4]
Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum
[5]
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
[6]
Université Libre de Bruxelles, Brussels, Belgium, Breast International Group, Brussels, Belgium
[7]
Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada
[8]
Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, MA, United States, Universit
[9]
Mayo Clinic Cancer Center, Jacksonville, FL, United States
[10]
Breast Unit, Royal Marsden Hospital, Institute of Cancer Research, London, United Kingdom
[11]
Université Libre de Bruxelles, Brussels, Belgium, Breast European Adjuvant Study Team (BrEAST) Data
[12]
GlaxoSmithKline, Collegeville PA, United States
[13]
Grupo Brasileiro de Estudos do Cancer de Mama (GBECAM) S?o Paulo, Brazil, Instituto Nacional de
[14]
Department of Medical Oncology, National Institute of Oncology, Budapest, Hungary
[15]
Frontier Science, Kingussie, Kincraig, United Kingdom
[16]
Australian and New Zealand Breast Cancer Trials Group, Australia
[17]
Breast European Adjuvant Study Team (BrEAST) Data Centre, Brussels, Belgium
[18]
发布时间
2013-11-20
换一批
